Emergent BioSolutions Shares Slide as Third-Quarter Revenue Shrinks
Emergent BioSolutions shares fell premarket after the company swung to a third-quarter loss amid a sharp drop in orders from the U.S. government and elsewhere.
By Rob CurranShares of Emergent BioSolutions tumbled premarket after the maker of opioid overdose remedies and other emergency medications swung to a third-quarter loss due to a sharp drop in orders from the U.S. government and elsewhere.The company, which also makes antidotes for anthrax and other…